| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/1992 | EP0217816B1 Elastin-based product, method for the preparation thereof and biological application thereof, particularly as biomaterials and artificial supports |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116951 Substantially pure interleukin-9 receptor and uses thereof |
| 05/26/1992 | US5116950 Sugar, amino acid, magnesium compound |
| 05/26/1992 | US5116949 Benzoyl urea compound-albumin complex |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | US5116942 Protein having an inflammatory phospholipase a2 inhibitory activity |
| 05/26/1992 | US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
| 05/26/1992 | US5116861 Treatment of Hypertension and Angina Pectoris |
| 05/26/1992 | US5116839 Treatment of senility |
| 05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
| 05/26/1992 | US5116828 Pharmaceutical composition for treatment of osteoporosis |
| 05/26/1992 | US5116818 Method and kit for contraception with GnRH-antagonist |
| 05/26/1992 | US5116817 LHRH preparations for intranasal administration |
| 05/26/1992 | US5116816 Immunosuppressants, antiinflammatory, parasiticides |
| 05/26/1992 | US5116738 Osteoinductive proteins; wound healing agents |
| 05/26/1992 | US5116622 3-/N-Phenylacetylamino/Piperidine-2,6-Dione, Urine Peptide |
| 05/26/1992 | US5116616 Use of intratracheal administration of SOD to protect humans from lung injury due to hyperoxia and hyperventilation |
| 05/26/1992 | US5116615 Method for treating benign prostatic hypertrophy |
| 05/26/1992 | US5116614 Jomol derivatives as agents for the use in malignant tumors and lowered immune defenses |
| 05/26/1992 | US5116389 Method of obtaining collagen human-skin fibers, fibers thus produced, and a compound containing them |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/26/1992 | CA1301680C Process of preparing physiologically active proteinaceous solutions |
| 05/26/1992 | CA1301650C Method of enhancing the bioactivity of atrial peptides |
| 05/24/1992 | CA2055961A1 Active fragments of fibroblast growth factor |
| 05/22/1992 | WO1992009556A1 Improved matrix metalloprotease inhibitors |
| 05/22/1992 | CA2096221A1 Matrix metalloprotease inhibitors |
| 05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
| 05/22/1992 | CA2055168A1 Tnf-muteins |
| 05/21/1992 | WO1992008475A1 Therapeutic agent for skin or corneal disease |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
| 05/20/1992 | EP0486425A2 High acid system nutritional formulations |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0486011A2 Pharmaceutical composition against Pneumocystis carinii |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485961A1 Oncostatin M for stimulating LDL uptake and LDL receptor expression |
| 05/20/1992 | EP0485611A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
| 05/20/1992 | EP0485532A1 Fucosyl transferases involved in adhesion molecule expression |
| 05/20/1992 | EP0485530A1 TGF-$g(b) PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |
| 05/20/1992 | EP0485486A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby. |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485458A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same. |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0437556A4 Substitution analogues of magainin peptides |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0209539B1 Homogeneous erythropoietin |
| 05/19/1992 | US5115098 End-blocked peptides inhibiting binding capacity of gp120 |
| 05/19/1992 | US5115096 Amphiregulin: a bifunctional growth modulating glycoprotein |
| 05/19/1992 | US5114962 New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof |
| 05/19/1992 | US5114953 Peptides |
| 05/19/1992 | US5114943 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 05/19/1992 | US5114932 Synthetic blood; oxygen carrier; surgery |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114926 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses |
| 05/19/1992 | US5114925 Renin inhibitors containing the 2-[[(2R,3S)-3-amino-4-cyclohexyl-2-hydroxy-1-butyl]thio)alkanoyl moiety and the corresponding sulfoxide and sulfone derivatives |
| 05/19/1992 | US5114923 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114921 Amphiphilic peptides and use thereof |
| 05/19/1992 | US5114920 BU-3292T antibiotics |
| 05/19/1992 | US5114918 Endothelin antagonistic cyclic pentapeptides |
| 05/19/1992 | US5114917 Arthritis treatment with enzyme inhibitors |
| 05/19/1992 | US5114916 Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants |
| 05/19/1992 | US5114851 Serine- or cysteine-containing protease modified by nucleophilic cinnamic acid; photoisomerization; biological switches; medical diagnosis |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114843 Humoral hypercalcemic factor antagonists |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114722 Medicament from peyer's patches |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114712 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | US5114710 M-csf as a therapeutic agent for thrombocytopenia |
| 05/19/1992 | CA1301181C2 Oxiranes |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/19/1992 | CA1301063C Biologically degradable superparamagnetic materials for use in clinicalapplications |
| 05/18/1992 | CA2055635A1 Antiviral activity of the rep gene encoded by adenoassociated virus type 2 |
| 05/17/1992 | WO1992008792A2 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/17/1992 | CA2096329A1 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/16/1992 | WO1992008726A1 Rat thyrotropin receptor gene and uses thereof |
| 05/16/1992 | WO1992008709A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2095013A1 Rat thyrotropin receptor gene and uses thereof |
| 05/16/1992 | CA2073776A1 Meta-substituted phenyl alanine derivatives |
| 05/15/1992 | WO1992008742A1 N-halochitosans, their preparation and uses |
| 05/15/1992 | WO1992008482A1 Compositions for reducing oxidative injury |
| 05/15/1992 | WO1992008481A1 Stabilized, potent grf analogs |
| 05/15/1992 | CA2096333A1 Compositions for reducing oxidative injury |
| 05/15/1992 | CA2092906A1 Stabilized, potent grf analogs |
| 05/15/1992 | CA2055115A1 A process for preparing a pharmaceutical composition |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007945A1 Cell type specific alteration of levels of gene products in neural cells |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007940A2 Bovine respiratory syncytial virus genes |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |